---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-021411"
form_type: "8-K"
ticker: "NKTR"
cik: "0000906709"
company_name: "NEKTAR THERAPEUTICS"
filed_at: "2022-04-25T23:59:59+00:00"
generated_at: "2026-06-26T05:13:41.086123+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Nektar announces strategic reorganization, 70% workforce reduction, cash runway to H1 2025

## Summary
- Workforce reduced by ~70%; expects charge of $150-160M in Q2 2022.
- Cash runway extended into first half of 2025; Q1 2022 cash & investments ~$704M.
- CMO Dr. Dimitry Nuyten stepping down; Dr. Brian Kotzin to succeed.
- CCO John Northcott to depart June 2022; remains as strategic advisor through 2022.
- Preliminary Q1 revenue ~$25M; R&D expense ~$110M; gain of ~$33M from SFJ derivative.

## SEC filing metadata
- accession: 0001213900-22-021411
- form_type: 8-K
- ticker: NKTR
- cik: 0000906709
- company_name: NEKTAR THERAPEUTICS
- filed_at: 2022-04-25T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 7.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/906709/000121390022021411/0001213900-22-021411-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/906709/000121390022021411/ea158792-8k_nektarthera.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-021411
- JSON: https://secwatch.observer/filing/0001213900-22-021411.json
- Plain text: https://secwatch.observer/filing/0001213900-22-021411.txt

## Key facts
- Executive change
  John Northcott departed as Senior Vice President and Chief Commercial Officer at NEKTAR THERAPEUTICS.
  - Action: step down
  - Role: Senior Vice President and Chief Commercial Officer
  source text: John Northcott will step down as Senior Vice President and Chief Commercial Officer of the Company in June 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/906709/000121390022021411/0001213900-22-021411-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.